Literature DB >> 11056365

Radiotracer synthesis from [(11)C]-iodomethane: a remarkably simple captive solvent method.

A A Wilson1, A Garcia, L Jin, S Houle.   

Abstract

A new method of [(11)C]-methylation is described, which attains the goals of simplicity, high radiochemical yields, speed, versatility, and automation. A standard high performance liquid chromatography (HPLC) injection loop on a standard HPLC injection valve is loaded with a solution (80 microL) of precursor (0.3-1.0 mg) in dimethyl formamide (DMF) or dimethyl sulfoxide (DMSO) (+ base if required). At ambient temperature [(11)C]-iodomethane is passed through the loop for 3-4 min with >90% trapping of activity. After a further 1-5 min, the contents of the loop are quantitatively injected onto the HPLC column for purification. Radiochemical yields are equal to or superior to conventional solution methods in all cases, even though no heat is applied. [(11)C]-labeled radiotracers that have been prepared by this method for human or animal studies include Raclopride, N-methylspiperone, Ro 15-1788, FLB 457, RTI-32, Rolipram, SCH 23390, and SKF 82957. Since no vials, transfer lines, cooling, heating, or sealing valves are required, no transfer losses occur, yields are high, and cleanup is minimal, this "loop method" is ideal for most radiopharmaceuticals prepared from [(11)C]-iodomethane.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11056365     DOI: 10.1016/s0969-8051(00)00132-3

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  51 in total

1.  Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PET.

Authors:  Robert A Comley; Cristian Salinas; Romina Mizrahi; Irina Vitcu; Alvina Ng; William Hallett; Nicholas Keat; Alan A Wilson; Eugenii A Rabiner; Marc Laruelle; Sylvain Houle
Journal:  Mol Imaging Biol       Date:  2012-08       Impact factor: 3.488

2.  Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial.

Authors:  Shinichiro Nakajima; Hiroyuki Uchida; Robert R Bies; Fernando Caravaggio; Takefumi Suzuki; Eric Plitman; Wanna Mar; Philip Gerretsen; Bruce G Pollock; Benoit H Mulsant; David C Mamo; Ariel Graff-Guerrero
Journal:  Schizophr Bull       Date:  2015-07-28       Impact factor: 9.306

3.  Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET/CT in healthy human volunteers.

Authors:  Arthur L Brody; Kyoji Okita; Jennifer Shieh; Lidia Liang; Robert Hubert; Michael Mamoun; Judah Farahi; Mark A Mandelkern
Journal:  Nucl Med Biol       Date:  2014-08-01       Impact factor: 2.408

4.  A dose-finding study of duloxetine based on serotonin transporter occupancy.

Authors:  Akihiro Takano; Kazutoshi Suzuki; Jun Kosaka; Miho Ota; Shoko Nozaki; Yoko Ikoma; Shuji Tanada; Tetsuya Suhara
Journal:  Psychopharmacology (Berl)       Date:  2006-02-28       Impact factor: 4.530

5.  Fast and repetitive in-capillary production of [18F]FDG.

Authors:  Hans-Jürgen Wester; Bent Wilhelm Schoultz; Christina Hultsch; Gjermund Henriksen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-27       Impact factor: 9.236

6.  [(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy.

Authors:  Ludwig Rinnab; Joerg Simon; Richard E Hautmann; M V Cronauer; Kathrin Hohl; Andreas K Buck; Sven N Reske; Felix M Mottaghy
Journal:  World J Urol       Date:  2009-02-21       Impact factor: 4.226

7.  In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.

Authors:  Abraham Martín; Nuria Vázquez-Villoldo; Vanessa Gómez-Vallejo; Daniel Padro; Federico N Soria; Boguslaw Szczupak; Sandra Plaza-García; Ander Arrieta; Torsten Reese; Jordi Llop; Maria Domercq; Carlos Matute
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-10       Impact factor: 9.236

8.  Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging.

Authors:  Sean R Donohue; Joseph H Krushinski; Victor W Pike; Eyassu Chernet; Lee Phebus; Amy K Chesterfield; Christian C Felder; Christer Halldin; John M Schaus
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

9.  Preclinical Evaluation of the First Adenosine A1 Receptor Partial Agonist Radioligand for Positron Emission Tomography Imaging.

Authors:  Min Guo; Zhan-Guo Gao; Ryan Tyler; Tyler Stodden; Yang Li; Joseph Ramsey; Wen-Jing Zhao; Gene-Jack Wang; Corinde E Wiers; Joanna S Fowler; Kenner C Rice; Kenneth A Jacobson; Sung Won Kim; Nora D Volkow
Journal:  J Med Chem       Date:  2018-11-13       Impact factor: 7.446

10.  [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy.

Authors:  Sven N Reske; Norbert M Blumstein; Gerhard Glatting
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-09       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.